Revvity reported 40.39 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Adcock Ingram Holdings 12.74 1.79 Jun/2024
Agilent 28.28 1.45 Jul/2025
Align Technology 29.36 1.09 Jun/2025
Bio Techne 34.54 25.29 Jun/2025
Bio-Rad Laboratories 33.52 26.2 Jun/2025
Bruker 33.4 21.52 Jun/2025
Celltrion 91.32 14.94 Mar/2025
Charles River Laboratories 27.65 0.86 Jun/2025
Cspc Pharmaceutical 12.94 0.45 Mar/2025
Danaher 37.11 1.64 Jun/2025
Dentsply International 8.46 22.2 Jun/2025
Divis Laboratories Ltd 87.49 13.33 Jun/2025
Edwards Lifesciences 30.42 0.55 Jun/2025
Hologic 27.38 10.48 Jun/2025
Illumina 12.94 26.14 Jun/2025
Intuitive Surgical 76.08 1.06 Jun/2025
IQVIA Holdings 20.69 1.92 Jun/2025
Kangmei Pharma 126.35 9.9 Sep/2024
Knight Therapeutics 43.03 21.94 Dec/2021
Laboratorios Farma 20.04 0.23 Jun/2025
Laboratory Of America 22.77 2.34 Jun/2025
Malin Corporation 11.81 0.72 Jun/2023
Medical Developments International 1.17K 765.75 Jun/2020
Mettler Toledo International 29.33 0.16 Jun/2025
Neuren Pharmaceuticals 13.64 3.76 Jun/2024
Pharma Mar 70.33 15.83 Jun/2025
Qiagen NV 24.01 79.75 Jun/2025
Quest Diagnostics 20.78 1.22 Jun/2025
Quidel 72.42 16.77 Sep/2024
Repligen 155.13 521.32 Jun/2025
Revvity 40.39 5.61 Jun/2025
Sartorius 156.52 20.01 Jun/2025
Sino Biopharmaceutical 27.73 0.61 Jun/2024
Thermo Fisher Scientific 22.09 4.79 Jun/2025
Waters 31.72 1.07 Jun/2025
Zz Pientze Pharmaceu 44.7 5.04 Jun/2025